BRIEF-Proqr Prices $50.0 Million Underwritten Registered Direct Offering And Concurrent Private Placement

ProQR Therapeutics N.V.

ProQR Therapeutics N.V.

PRQR

0.00

June 25 (Reuters) - ProQR Therapeutics NV PRQR.O:

  • PROQR PRICES $50.0 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT

  • PROQR THERAPEUTICS NV - ELI LILLY TO PURCHASE 5.1 MILLION PROQR SHARES AT $1.81/SHARE FOR $9.2 MILLION

  • PROQR THERAPEUTICS NV - TO USE PROCEEDS FOR RESEARCH, CLINICAL DEVELOPMENT, AND GENERAL CORPORATE PURPOSES

Source text: ID:nGNX5vSLsz

Further company coverage: PRQR.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.